The acquisition brought an extensive new line-up of products to the Union, NJ-based MORRE-Tec. “Vitacyclix, a Yonkers, New York company [is] known for its quality vitamins, nutrients and bioflavonoids for fortification in food, dairy, beverage and nutritional products,” the press release said.
According to the release, Glass cited Vitacyclix as the “dairy fortification pioneer that actually developed and launched the original vitamin A and D concentrates more than 55 years ago under their flagship brand, Freeman Dairy vitamins A&D.”
Timing it right
MORRE-Tec’s leadership explained why the acquisition was a timely and relevant decision. “Experts believe that more than one billion individuals are vitamin D deficient, which is significant because of the well-established negative effects of this deficiency,” said Michael Glass, MORRE-TEC’s director of sales and marketing.
Vice President of Administration and Special Projects William Ludlum added that MORRE-Tec’s customers will recognize the acquisition as strategic growth into new areas of functional ingredients.
“This will lead to more opportunities for our products and services to support their needs,” Ludlum said. “By expanding our core product line with new functional ingredients and technologies, MORRE-Tec is in prime position to support manufacturers with the fortification ingredients that address their long-term needs.”